Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Whistleblowing in science: this physician faced ostracization after standing up to pharma

Find a new job

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-024-02743-5

This interview has been edited for length and clarity.

Updates & Corrections

  • Correction 27 August 2024: An earlier version of this story erroneously indicated that Nancy Olivieri questioned the legality of using unlicensed drugs in clinical trials.

References

  1. Olivieri, N. F. et al. N. Engl. J. Med. 339, 417–423 (1998).

    Article  PubMed  Google Scholar 

  2. Olivieri, N. F., Sabouhanian, A. & Gallie, B. L. PLoS ONE 14, e0211942 (2019).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links